We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The Secretary of State permitted the use of 3 unauthorised bluetongue serotype 3 (BTV-3) vaccines within the United Kingdom yesterday (4 September).
Revisions to the charges for delivering the statutory annual surveillance programme in England, Scotland and Wales.
Register your company and Schedule 6 products with the VMD before the deadline.
Summary of responses and government response to the consultation on revised charges for the National Residues Control Programme.
Product defect recall alert for Milprazon Chewable 12.5 mg/125 mg Film-coated Tablets for Dogs Weighing at Least 5 kg Vm 01656/5083 by Krka Ltd.
Important safety information regarding patient selection and monitoring, to minimise the risk of adverse events.
All in-date batches of Kexxtone 32.4g continuous-release intraruminal device for cattle are being recalled with immediate effect.
Product defect recall alert for Aquacare Swimbladder Treatment by N.T. Laboratories Ltd.
In-person training course at the Hilton Birmingham Metropole on Wednesday 16 October 2024.
Increase in suspected adverse event reports following use of Caninsulin 40 IU/ml Suspension for Injection.
Changes to our special imports digital service will affect UK veterinary surgeons and WDA holders who hold and supply imported medicines.
Change to the information provided on adverse events in the Summary of Product Characteristics for Neptra Ear Drops Solution for Dogs.
Results of our 2024 pharmaceutical industry customer survey carried out by an independent party.
Change to the information provided on adverse events in the Summary of Product Characteristics for Cimalgex 8 mg / 30 mg / 80 mg Chewable Tablets for Dogs.
Change to the information provided on adverse events in the Summary of Product Characteristics for Propalin Syrup, 40 mg/ml Dogs.
Recall alert for Johnson’s 4Fleas 11.4 mg Tablets for Cats and Kittens 6-tablet pack for incorrect packaging relating to 4Fleas Tablets for Dogs 6-tablet pack.
VICH consultation until 30 November 2024 on guidelines relating to the technical requirements for demonstrating genotoxic safety of residues of veterinary drugs in human food.
New legislation in force from today in Great Britain makes changes to the requirements set out in the Veterinary Medicines Regulations 2013.
New legislation in Great Britain will make changes to the requirements set out in the Veterinary Medicines Regulations 2013.
From 13 May 2024 we are introducing a change to the procedure for new Marketing Authorisation (MA) applications, where a joint assessment of labels is requested.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).